Amyotrophic Lateral Sclerosis
📧 Sign up to get email alerts when something new happens for Amyotrophic Lateral Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-09-09FDA Approved: RILUZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's supplemental application for riluzole, authorizing the marketing of a generic riluzole product in the Unit…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]
A study update for Acthar Gel in amyotrophic lateral sclerosis (ALS) shows the trial was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: The Use of Airway Clearance Devices in ALS [NA]
A completed clinical trial evaluating airway clearance devices in amyotrophic lateral sclerosis with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Dual Treatment With Lithium and Valproate in ALS. [Phase 2]
Phase 2 trial evaluating dual therapy with lithium and valproate in amyotrophic lateral sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
A Phase 2 trial evaluating the swallowing safety of riluzole oral soluble film in ALS was terminated with results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS
A completed clinical trial investigating speech degradation as an indicator of physiological degeneration in amyotrophic lateral sclerosis; …
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Open-label Clinical Trial of Lacosamide in ALS [Phase 1, Phase 2]
Open-label clinical trial of lacosamide in amyotrophic lateral sclerosis has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year [Phase 3]
Phase 3 trial update on tirasemtiv in amyotrophic lateral sclerosis with longitudinal assessment after one year; results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis [Phase 2]
Phase 2 trial investigating plasma exchange with albumin for amyotrophic lateral sclerosis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
A Phase 2 clinical trial assessing pimozide in patients with amyotrophic lateral sclerosis (ALS) has been announced; current status is unkno…
-
FDA label_change · 2020-05-11FDA Approved: TIGLUTIK — Supplemental Application (EDW PHARMA, INC)
FDA approved a supplemental application for Tiglutik (riluzole) submitted by EDW Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Electronic-health Application To Measure Outcomes REmotely Clinical Trial [NA]
A completed clinical trial using an electronic health application to measure outcomes remotely in neurodegenerative disease contexts, with r…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 clinical trial of CK-2017357 in amyotrophic lateral sclerosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 clinical trial update on rasagiline in subjects with Amyotrophic Lateral Sclerosis (ALS) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) [Phase 1, Phase 2]
A pilot Phase 1/2 trial evaluating triheptanoin in people with amyotrophic lateral sclerosis (ALS) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: A Trial of Tocilizumab in ALS Subjects [Phase 2]
Phase 2 trial of tocilizumab in ALS completed with results posted in 2019.
-
FDA approval · 2019-12-13FDA Approved: TIGLUTIK — Supplemental Application (EDW PHARMA, INC)
The FDA approved a supplemental application for TIGLUTIK (riluzole) submitted by EDW Pharma, Inc.
-
FDA approval · 2019-12-09FDA Approved: RILUZOLE — Original Application (Florida Pharmaceutical Products, LLC)
The FDA approved an original Abbreviated New Drug Application for riluzole from Florida Pharmaceutical Products, LLC, establishing a generic…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis [NA]
A rehabilitative trial evaluating transcranial direct current stimulation (tDCS) in amyotrophic lateral sclerosis has completed, with result…
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: CuATSM Compared With Placebo for Treatment of ALS/MND [Phase 2, Phase 3]
A phase 2/3 trial evaluating CuATSM versus placebo for amyotrophic lateral sclerosis (ALS) is ongoing, with an unknown current status.
-
FDA approval · 2019-11-01FDA Approved: RADICAVA — Supplemental Application (Shionogi Inc.)
The FDA approved a supplemental application for RADICAVA (edaravone) submitted by Shionogi Inc.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Phase 2 clinical trial investigating the efficacy and safety of vitamin E mixed tocotrienols in patients with amyotrophic lateral sclerosis …
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Tamoxifen Treatment in Patients With Motor Neuron Disease [Phase 1, Phase 2]
Clinical trial update on tamoxifen treatment in patients with motor neuron disease (ALS), encompassing Phase 1 and Phase 2 completed.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Clinical Trial of Ezogabine (Retigabine) in ALS Subjects [Phase 2]
A Phase 2 clinical trial of ezogabine (retigabine) in Amyotrophic Lateral Sclerosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Safety and Feasibility of the EyeControl Device [NA]
Completed clinical trial assessing safety and feasibility of the EyeControl device for ALS.